相关实验视频
Updated: Sep 15, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
开发和验证虚拟人口模型,用于预测北美民族人口中的药物药理动力学
Udoamaka Ezuruike1, Jean Dinh1,2, Eman El-Khateeb1,3
1Certara Predictive Technologies, Sheffield, UK.
这项研究开发了四个北美人口档案,用于基于生理学上的药理动力学 (PBPK) 建模. 这些文件解释了药物药理动力学 (PK) 和药物相互作用 (DDI) 的种族差异,有助于为不同人群开发药物.
科学领域:
- 药理动力学和药物新陈代谢
- 计算生物学和生物信息学
- 人口遗传学和基因组学
背景情况:
- 种族差异显著影响药物药理动力学 (PK) 和药物相互作用 (DDI).
- 准确的建模需要特定人群的生理和生化数据.
- 现有的模型可能无法充分捕捉北美人口的多样性.
研究的目的:
- 开发四个不同的北美 (NA) 亚种群文件 (白人,非洲裔美国人,亚裔美国人,西班牙裔/拉丁裔) 用于生理学基础的药理动力学 (PBPK) 建模.
- 将人口统计数据,生理参数和特定种族的共同变量关系纳入这些PBPK模型.
- 加强对不同纳粹民族群体的药物暴露和DDI后果的预测.
主要方法:
- 对每个NA亚种群的统计人口统计数据,组织参数,血流,心脏输出,血蛋白水平,血红素,酶/输送物丰度,功能和胃肠道传输时间.
- 开发了针对每个种族特有的共同变量关系的方程.
- 经验证的PBPK模型使用了20项研究的临床数据 (6项人群特异性PK,14个混合NA包括6个DDI).
主要成果:
- 确定了关键的种族差异,例如非洲裔美国人中较高的CYP3A5 / OATP1B1和亚裔美国人中较低的CYP3A4 / OATP1B1.
- 突出了CYP2C9等位基因频率的变化,在非裔美国人和西班牙裔/拉丁裔中增加了低活性等位基因.
- 与观察到的数据对比验证的PBPK模拟,显示结果在两倍差距内.
- 用repaglinide进行的PBPK模拟预测了白人,亚洲人和非洲裔美国人群中的显著暴露差异.
结论:
- 开发的NA人口文件使PBPK建模能够解释药物动力学中的种族变异性.
- 这些档案可以改善预测药物暴露和DDI结果在不同的NA人口的特定子组.
- PBPK建模方法有助于为不同种族群体制定个性化药物开发策略.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
相关概念视频
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...